Nonylphenol affects myocardial contractility and L-type Ca2+ channel currents in a non-monotonic manner via G protein-coupled receptor 30

Toxicology

Volumn 334, Issue , 2015, Pages 122-129

  Gao, Qinghua ^a   Liu, Shuyuan ^a   Guo, Feng ^a   Liu, Shuice ^a   Yu, Xiangchen ^a   Hu, Huiyuan ^a   Sun, Xuefei ^a   Hao, Liying ^a   Zhu, Tong ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b NORTHEASTERN UNIVERSITY   (China)

Author keywords

Cardiac myocytes; GPR30; L type Ca2+ current; Nonylphenol; Xenoestrogen

Indexed keywords

CALCIUM CHANNEL L TYPE; ESTROGEN; G PROTEIN COUPLED RECEPTOR; GPR30 PROTEIN, RAT; NONYLPHENOL; PHENOL DERIVATIVE;

ANIMAL; CALCIUM SIGNALING; DOSE RESPONSE; DRUG EFFECTS; FEMALE; GUINEA PIG; HEART CONTRACTION; HEART MUSCLE CELL; KINETICS; MEMBRANE POTENTIAL; METABOLISM; PERFUSION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGENS; FEMALE; GUINEA PIGS; KINETICS; MEMBRANE POTENTIALS; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PERFUSION; PHENOLS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84934295902     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2015.06.004     Document Type: Article

References (32)

1. Aly H.A., Domenech O., Banjar Z.M. Effect of nonylphenol on male reproduction: analysis of rat epididymal biochemical markers and antioxidant defense enzymes. Toxicol. Appl. Pharmacol. 2012, 261:134-141.
2. Alyea R.A., Watson C.S. Nongenomic mechanisms of physiological estrogen-mediated dopamine efflux. BMC Neurosci. 2009, 10:59.
3. Berger F., Borchard U., Hafner D., Putz I., Weis T.M. Effects of 17beta-estradiol on action potentials and ionic currents in male rat ventricular myocytes. Naunyn- Schmiedebergs Arch. Pharmacol. 1997, 356:788-796.
4. Bulayeva N.N., Watson C.S. Xenoestrogen-induced ERK-1 and ERK-2 activation via multiple membrane-initiated signaling pathways. Environ. Health Perspect. 2004, 112:1481-1487.
5. 2+ levels and prolactin release in a pituitary cell line. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E388-397.
6. 2+ current inhibition. Acta Pharmacol. Sin. 2012, 33:615-624.
7. Chen Y., Li Z., He Y., Shang D., Pan J., Wang H., Chen H., Zhu Z., Wan L., Wang X. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis. Toxicol. Appl. Pharmacol. 2014, 275:176-181.
8. Fan G., Zhu Y., Guo H., Wang X., Wang H., Gao X. Direct vasorelaxation by a novel phytoestrogen tanshinone IIA is mediated by nongenomic action of estrogen receptor through endothelial nitric oxide synthase activation and calcium mobilization. J. Cardiovasc. Pharmacol. 2011, 57:340-347.
9. 2+ currents in a non-monotonic manner in GH3 pituitary cells. Toxicol. Lett. 2013, 218:137-143.
10. Huang Y., Huang Y.L., Lai B., Zheng P., Zhu Y.C., Yao T. Raloxifene acutely reduces glutamate-induced intracellular calcium increase in cultured rat cortical neurons via inhibition of high-voltage-activated calcium current. Neuroscience 2007, 147:334-341.
11. Hugo E.R., Brandebourg T.D., Woo J.G., Loftus J., Alexander J.W., Ben-Jonathan N. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ. Health Perspect. 2008, 116:1642-1647.
12. Jie X., Yang W., Jie Y., Hashim J.H., Liu X.Y., Fan Q.Y., Yan L. Toxic effect of gestational exposure to nonylphenol on F1 male rats. Birth Defects Res. B: Dev. Reprod. Toxicol. 2010, 89:418-428.
13. Kang L., Zhang X., Xie Y., Tu Y., Wang D., Liu Z., Wang Z.Y. Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Mol. Endocrinol. 2010, 24:709-721.
14. Komesaroff P.A., Black C.V., Westerman R.A. A novel, nongenomic action of estrogen on the cardiovascular system. J. Clin. Endocrinol. Metab. 1998, 83:2313-2316.
15. Liu S., Mauvais-Jarvis F. Rapid, nongenomic estrogen actions protect pancreatic islet survival. Islets 2009, 1:273-275.
16. Morley P., Whitfield J.F., Vanderhyden B.C., Tsang B.K., Schwartz J.L. A new, nongenomic estrogen action: the rapid release of intracellular calcium. Endocrinology 1992, 131:1305-1312.
17. Patel V.H., Chen J., Ramanjaneya M., Karteris E., Zachariades E., Thomas P., Been M., Randeva H.S. G-protein coupled estrogen receptor 1 expression in rat and human heart: protective role during ischaemic stress. Int. J. Mol. Med. 2010, 26:193-199.
18. Prins G.S. Endocrine disruptors and prostate cancer risk. Endocr. Relat. Cancer 2008, 15:649-656.
19. Riva C., Porte C., Binelli A., Provini A. Evaluation of 4-nonylphenol in vivo exposure in Dreissena polymorpha: bioaccumulation, steroid levels and oxidative stress. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2010, 152:175-181.
20. 2+ channels in smooth muscle cells. FASEB J. 1998, 12:613-619.
21. Silva E., Kabil A., Kortenkamp A. Cross-talk between non-genomic and genomic signalling pathways-distinct effect profiles of environmental estrogens. Toxicol. Appl. Pharmacol. 2010, 245:160-170.
22. Somjen D., Kohen F., Lieberherr M. Nongenomic effects of an anti-idiotypic antibody as an estrogen mimetic in female human and rat osteoblasts. J. Cell. Biochem. 1997, 65:53-66.
23. Song J., Standley P.R., Zhang F., Joshi D., Gappy S., Sowers J.R., Ram J.L. Tamoxifen (estrogen antagonist) inhibits voltage-gated calcium current and contractility in vascular smooth muscle from rats. J. Pharmacol. Exp. Ther. 1996, 277:1444-1453.
24. Strumylaite L., Mechonosina K., Tamasauskas S. Environmental factors and breast cancer. Medicina (Kaunas) 2010, 46:867-873.
25. Vandenberg L.N., Colborn T., Hayes T.B., Heindel J.J., Jacobs D.R.Jr., Lee D.H., Shioda T., Soto A.M., vom Saal F.S., Welshons W.V., Zoeller R.T., Myers J.P. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr. Rev. 2012, 33:378-455.
26. Vinas R., Watson C.S. Bisphenol S disrupts estradiol-induced nongenomic signaling in a rat pituitary cell line: effects on cell functions. Environ. Health Perspect. 2013, 121:352-358.
27. Watson C.S., Bulayeva N.N., Wozniak A.L., Alyea R.A. Xenoestrogens are potent activators of nongenomic estrogenic responses. Steroids 2007, 72:124-134.
28. Weltje L., vom Saal F.S., Oehlmann J. Reproductive stimulation by low doses of xenoestrogens contrasts with the view of hormesis as an adaptive response. Human Exp. Toxicol. 2005, 24:431-437.
29. Wong M., Thompson T.L., Moss R.L. Nongenomic actions of estrogen in the brain: physiological significance and cellular mechanisms. Crit. Rev. Neurobiol. 1996, 10:189-203.
30. 2+ fluxes and prolactin release in GH3/B6 pituitary tumor cells. Environ. Health Perspect. 2005, 113:431-439.
31. 2+ influx via L-type calcium channels activates the Src/ERK/cyclic-AMP response element binding protein signal pathway and BCL-2 expression in rat hippocampal neurons: a potential initiation mechanism for estrogen-induced neuroprotection. Neuroscience 2005, 135:59-72.
32. Zhang L., Li X., Zhao L., Zhang G., Wang J., Wei L. Nongenomic effect of estrogen on the MAPK signaling pathway and calcium influx in endometrial carcinoma cells. J. Cell. Biochem. 2009, 106:553-562.